Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 2
1981 3
1982 2
1983 4
1984 1
1985 4
1986 6
1987 4
1988 2
1989 4
1990 4
1991 3
1992 10
1993 3
1994 3
1995 6
1996 6
1997 6
1998 5
1999 8
2000 9
2001 7
2002 5
2003 8
2004 5
2005 12
2006 5
2007 11
2008 8
2009 10
2010 13
2011 11
2012 8
2013 8
2014 9
2015 4
2016 1
2018 2
2019 5
2020 6
2021 4
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

226 results
Results by year
Filters applied: . Clear all
Page 1
Defining the clinical course of multiple sclerosis: the 2013 revisions.
Lublin FD, Reingold SC, Cohen JA, Cutter GR, Sørensen PS, Thompson AJ, Wolinsky JS, Balcer LJ, Banwell B, Barkhof F, Bebo B Jr, Calabresi PA, Clanet M, Comi G, Fox RJ, Freedman MS, Goodman AD, Inglese M, Kappos L, Kieseier BC, Lincoln JA, Lubetzki C, Miller AE, Montalban X, O'Connor PW, Petkau J, Pozzilli C, Rudick RA, Sormani MP, Stüve O, Waubant E, Polman CH. Lublin FD, et al. Among authors: rudick ra. Neurology. 2014 Jul 15;83(3):278-86. doi: 10.1212/WNL.0000000000000560. Epub 2014 May 28. Neurology. 2014. PMID: 24871874 Free PMC article.
Beta-interferon for multiple sclerosis.
Rudick RA, Goelz SE. Rudick RA, et al. Exp Cell Res. 2011 May 15;317(9):1301-11. doi: 10.1016/j.yexcr.2011.03.002. Epub 2011 Mar 21. Exp Cell Res. 2011. PMID: 21396360 Review.
Author response.
Rudick RA, Miller A. Rudick RA, et al. Neurology. 2013 Feb 19;80(8):777. Neurology. 2013. PMID: 23544194 No abstract available.
Management of multiple sclerosis.
Rudick RA, Cohen JA, Weinstock-Guttman B, Kinkel RP, Ransohoff RM. Rudick RA, et al. N Engl J Med. 1997 Nov 27;337(22):1604-11. doi: 10.1056/NEJM199711273372207. N Engl J Med. 1997. PMID: 9371858 Review. No abstract available.
Oral treatment for multiple sclerosis.
Killestein J, Rudick RA, Polman CH. Killestein J, et al. Among authors: rudick ra. Lancet Neurol. 2011 Nov;10(11):1026-34. doi: 10.1016/S1474-4422(11)70228-9. Lancet Neurol. 2011. PMID: 22014437 Review.
Interferon-beta treatment for multiple sclerosis.
Bermel RA, Rudick RA. Bermel RA, et al. Among authors: rudick ra. Neurotherapeutics. 2007 Oct;4(4):633-46. doi: 10.1016/j.nurt.2007.07.001. Neurotherapeutics. 2007. PMID: 17920544 Free PMC article. Review.
Multiple sclerosis: disease markers accelerate progress.
Fox RJ, Rudick RA. Fox RJ, et al. Among authors: rudick ra. Lancet Neurol. 2004 Jan;3(1):10. doi: 10.1016/s1474-4422(03)00610-0. Lancet Neurol. 2004. PMID: 14693099 Review. No abstract available.
Measuring disability in relapsing-remitting MS.
Rudick RA, Kappos L. Rudick RA, et al. Neurology. 2010 Jul 27;75(4):296-7. doi: 10.1212/WNL.0b013e3181ecf815. Epub 2010 Jun 30. Neurology. 2010. PMID: 20592252 No abstract available.
Measuring treatment response to advance precision medicine for multiple sclerosis.
Calabresi PA, Kappos L, Giovannoni G, Plavina T, Koulinska I, Edwards MR, Kieseier B, de Moor C, Sotirchos ES, Fisher E, Rudick RA, Sandrock A. Calabresi PA, et al. Among authors: rudick ra. Ann Clin Transl Neurol. 2021 Nov;8(11):2166-2173. doi: 10.1002/acn3.51471. Epub 2021 Oct 26. Ann Clin Transl Neurol. 2021. PMID: 34704393 Free PMC article.
Drug treatment of multiple sclerosis.
Rudick RA, Schiffer RB, Herndon RM. Rudick RA, et al. Semin Neurol. 1987 Jun;7(2):150-9. doi: 10.1055/s-2008-1041415. Semin Neurol. 1987. PMID: 2845549 Review. No abstract available.
226 results